VP (Head), Product Strategy
Description
Cornerstone Search Group has been retained by a well-funded cardiovascular-focused biotech with a multi-asset, clinical-stage pipeline focused on diseases with no approved drug treatments. This newly created Vice President role reports into the C-Suite and will define and drive product strategy end-to-end across the firm’s entire portfolio. Working across the Regulatory, Clin Dev, Med Affairs, Commercial, and BD functions, you and your team will establish product visions, value propositions, differentiated positioning, and lifecycle strategies with the goal of maximizing each asset’s patient impact and long-term value.
Compensation: Competitive base salary, annual bonus, and an aggressive equity program
Location
New Jersey (commutable from most areas of New Jersey and Pennsylvania where pharma professionals tend to live)
Features
THREE HIGHLY ATTRACTIVE FEATURES:
- High Profile, High Impact Newly Created Role
- Reports to highly accomplished C-suite member with strong communication skills
- Well-funded: While many pre-commercial biotechs still struggle with funding, our client has raised significant capital due to the leadership team’s very successful biotech track record and the company’s exciting pipeline
- Exciting Pipeline: multiple asset clinical-stage pipeline for cardiovascular diseases with no FDA-approved treatments
Responsibilities
KEY ACCOUNTABILITIES:
- Direct reports - Manage and mentor Product Strategy Asset Leads and other direct reports.
- Strategic advisor to the C-suite on product- and portfolio-level decisions. Develop recommendations for program-related investments such as new indications and formulations.
- You and your team will lead the development and evolution of integrated product strategies across all company assets from early clinical stage through lifecycle management. This includes: (a) defining TPPs, value props, and differentiation strategies; (b) partnering with Clin Dev and Med Affairs on trial design, endpoints, and evidence generation activities; (c) collaborating with Regulatory and Market Access on approval pathway strategies, pricing considerations, and reimbursement dynamics; and (d) leading CI and market landscaping activities to inform your strategies.
- Create and own the overall cross-functional launch plans
Qualifications / Requirements
DESIRED SKILLS / QUALIFICATIONS / EXPERIENCES / BEHAVIORS:
- 10-15 years of relevant pharma/biotech experience which may include strategic pharma consulting firm experience
- Prior experience leading product strategy across clinical development stages
- Launch experience is preferred
- Prior involvement with launch planning, P&R planning, and developing evidence generation strategy.
- Cardiovasuclar-related experience is a plus
- Comfortable with being a player-coach. This is not just a manager role - you will have hands-on operational responsibility too.
- Prior direct experience is a plus
- High EQ coupled with persuasive communication, presentation, and influencing skills
- Flexibility to travel as needed
Contact
Recently Completed Retained Searches by Cornerstone
REPRESENTATIVE RETAINED SEARCH ASSIGNMENTS:- CEO | specialty pharma start-up
- CEO | regenerative medicine start-up
- US CEO | established European small pharma
- President/US Commercial Head | Generics Pharma
- CMO | late-stage public biotech
- CMO | mid-size pharma
- CSO | mid-size global biotech
- SVP, Head of Global Medical Affairs | mid-size oncology company
- SVP, Head of Global Clinical Development | multi-TA mid-size pharma
- SVP, Head of Global Regulatory Affairs | late-stage Israeli biotech
- Global Head, Oncology R&D | mid-size European pharma
- Group VP, Global Commercial Head | API Business Unit | Indian pharma
- VP, Data Science RWE | Top 5 Pharma
- VP, Head of Regulatory Affairs | Boston Biotech
- VP, US Head of Regulatory Affairs | Top 20 Pharma
- VP, Head of R&D Operations | Boston biotech
- VP, Head of HEOR (Health Economics & Outcomes Research | Top CNS specialty pharma
- VP, Head of US HEOR & RWE | Top 5 Pharma
- VP, Head of Real-World Evidence | Top 5 pharma
- VP, Head of US HEOR | Top Oncology Pharma
- ED, Head of HEOR | Top West Coast Pharma
- VP, Head of Global Market Access | Top Oncology Specialty Pharma
- VP, Head of US Market Access | High-profile late-stage biotech
- VP, Head of US Market Access | West Coast Late-Stage Public Biotech
- VP, Head of Heme/Onc Clinical Research | Public oncology biotech
- VP, Head of Clinical Development | late-stage anti-infectives UK pharma
- VP, Head of Global Drug Safety & PV | Chinese oncology biotech
- ED, Head of Clinical Operations | British VC-backed biotech
- ED, Global Commercial Strategy Franchise Head | Top rare disease Boston pharma
- ED, Head of Global Clinical Pharmacology | Public oncology biotech
- ED, Head of Global HEOR | Large US Pharma
- Head, Patient Advocacy | European commercial-stage rare disease biotech
- Medical Directors (Director/SD/ED levels) in Translational Medicine / Clinical Development / Medical Affairs / Drug Safety: 75+ retained assignments
- HEOR/RWE/Market Access (AD/Director/SD/ED levels): 100+ retained assignments
Cornerstone's Privacy Policy
Cornerstone Search Group considers all inquiries, resume submissions, and any other personal information submitted to us as confidential information. This information will not be shared with any parties outside of Cornerstone Search Group without your prior permission.